ScholarLens Back to search
1993•PubMedRequires access

A comparative clinical study on prevention and treatment with selected chronomedication of leukopenia induced by chemotherapy.

Y Li, Yu Gao

Open publisher page 1 citations

Abstract

During the period of therapy, leukopenia induced by chemotherapy was less severe and was cured more rapidly in the selected chronomedication group (CMG) than in the routine medication group (RMG). The incidence of leukopenia was markedly lower in CMG (12.9%) than in RMG (48.4%), and the rate of uneventful completion of chemotherapy was also higher in CMG (96.8%) than in RMG. These results suggest that selected chronomedication may be beneficial to the successful completion of chemotherapy in patients with malignant tumor.

About this research paper

What this paper is about

During the period of therapy, leukopenia induced by chemotherapy was less severe and was cured more rapidly in the selected chronomedication group (CMG) than in the routine medication group (RMG). The incidence of leukopenia was markedly lower in CMG (12.9%) than in RMG (48.4%), and the rate of uneventful completion of chemotherapy was also higher in CMG (96.8%) than in RMG. These results suggest that selected chronomedication may be beneficial to the successful completion of chemotherapy in patients with malignant tumor.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

During the period of therapy, leukopenia induced by chemotherapy was less severe and was cured more rapidly in the selected chronomedication group (CMG) than in the routine medication group (RMG). The incidence of leukopenia was markedly lower in CMG (12.9%) than in RMG (48.4%), and the rate of uneventful completion of chemotherapy was also higher in CMG (96.8%) than in RMG. These results suggest that selected chronomedication may be beneficial to the successful completion of chemotherapy in patients with malignant tumor.

Key concepts: Leukopenia, Medicine, Chemotherapy, Incidence (geometry), Internal medicine, Surgery, Gastroenterology, Optics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A comparative clinical study on prevention and treatment with selected chronomedication of leukopenia induced by chemotherapy. — Research Paper | ScholarLens